A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4
about
Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model VerificationDrug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes?Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19Influence of gestational diabetes on the stereoselective pharmacokinetics and placental distribution of metoprolol and its metabolites in parturients.Development of Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Indomethacin Disposition in PregnancyPharmacologic studies in vulnerable populations: Using the pediatric experience.Physiologically-based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant women.Physiologically Based Modelling of Darunavir/Ritonavir Pharmacokinetics During Pregnancy.Application of a Physiologically Based Pharmacokinetic Model to Study Theophylline Metabolism and Its Interactions With Ciprofloxacin and Caffeine.A Semi-Mechanistic Metabolism Model of CYP3A Substrates in Pregnancy: Predicting Changes in Midazolam and Nifedipine Pharmacokinetics.Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models.A PBPK Model to Predict Disposition of CYP3A-Metabolized Drugs in Pregnant Women: Verification and Discerning the Site of CYP3A Induction.A physiologically based pharmacokinetic model to predict disposition of CYP2D6 and CYP1A2 metabolized drugs in pregnant women.A simplified PBPK modeling approach for prediction of pharmacokinetics of four primarily renally excreted and CYP3A metabolized compounds during pregnancyObstetric Pharmacokinetic Dosing Studies are Urgently Needed.Prediction of drug disposition on the basis of its chemical structure.Models for evaluating the pharmacokinetics and pharmacodynamics for β-blockers.Clinical applications of CYP genotyping in psychiatry.Regulation of drug transporter expression and function in the placenta.Prediction of Fetal Darunavir Exposure by Integrating Human Ex-Vivo Placental Transfer and Physiologically Based Pharmacokinetic Modeling.Application of physiologically based pharmacokinetic modeling to predict drug disposition in pregnant populations.Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in Pregnancy.Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women.Fetal Physiologically-Based Pharmacokinetic Models: Systems Information on Fetal Biometry and Gross Composition.Drug Dosing in Pregnant Women: Challenges and Opportunities in Using Physiologically Based Pharmacokinetic Modeling and Simulations.Reverse Translation in PBPK and QSP: Going Backwards in Order to Go Forward With Confidence.Inclusion of pregnant and breastfeeding women in research - efforts and initiatives.A Physiologically-Based Pharmacokinetic Model to Predict Human Fetal Exposure for a Drug Metabolized by Several CYP450 Pathways.Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the model for passive placental permeability drugs.Effect of type 2 diabetes mellitus on the pharmacokinetics and transplacental transfer of nifedipine in hypertensive pregnant women.Pregnancy and pharmacogenomics in the context of drug metabolism and response.Physiologically based pharmacokinetic models for the optimization of antiretroviral therapy: recent progress and future perspective
P2860
Q28088352-81B58AAF-C954-4779-B28F-C09D2239EDDFQ34323195-ED1F90EA-9E50-44EF-8529-4099D6DFD351Q35211432-C5695753-1C2B-4468-9808-894ECBF7193CQ35286070-61DE821F-D67A-41E3-9096-827AE8B2999AQ35797203-124241CA-E304-4AAB-9892-8323E20BA075Q36235896-6755C7A7-65D8-48B2-B485-5B77903AC66AQ36243626-5C7AA6D9-A8B4-4950-B279-7AB10E821708Q36599597-DC9FDBA5-46D7-40E2-B1DA-0D21EDBE9EB8Q36600064-B0463C6E-5B8F-47AC-9C5C-7CDD1166EBC9Q36702463-0AD8ECCF-2B4B-4350-802F-C80B14E5E618Q36706781-6D83F2E9-7FAB-4F49-A16E-FF7E4C8E1398Q36712344-74B8BD96-F623-46AF-A19F-357320E055E4Q36717181-ADBDEEDC-110C-42D6-AAD2-C3FF9572A677Q37207844-B9D23F7C-7CE6-4A10-BE54-F3A16D3942A4Q37575742-2D73F0F9-14F9-479B-8B26-1C0680C45F23Q38086778-5F9D92A3-BD93-43AD-A779-34A1372866E0Q38193200-5D37C5E7-65D9-464E-A459-0EA5E9641175Q38247063-E536943E-F63A-4F41-AE07-EE2CAEC626E2Q38323562-FB2B8C24-DCD8-45DC-A490-BBEF828117B7Q38661049-9C9F9EBC-D38C-4121-81B8-19918A7BE01AQ38802632-4012874B-F19D-4A61-B1A0-4F61F3446842Q38841163-C59ACBE9-3032-4F05-93A1-07AB20EECD3BQ38846048-BB7DC75D-FEC1-4BC6-A5B9-BA660EA51043Q47271636-F0A6E0C6-664C-45E0-B467-33E6E4F39A0EQ47724161-0A7E10C6-A462-4396-9A4C-49CDC67D6131Q47813133-B243C78F-B47E-49E6-84D0-8CAD264E88BBQ47963328-86A645B0-6D2B-4030-9F63-46D541BFD55DQ48072950-0D7449EE-E95C-4AEB-B5AA-C0B47CD30282Q50974898-2553A2FD-B4B3-4C07-941D-8D40D75C0873Q50977791-BD6DAEDE-41E9-4065-B1E6-24B5CE4CF54AQ54659609-72B5C6E3-1D2A-449E-A696-4DC4DEF70375Q58073610-6558FCFD-AFD0-4DB4-8542-BD53654F68B2
P2860
A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
A pregnancy physiologically ba ...... d by CYP1A2, CYP2D6 and CYP3A4
@ast
A pregnancy physiologically ba ...... d by CYP1A2, CYP2D6 and CYP3A4
@en
type
label
A pregnancy physiologically ba ...... d by CYP1A2, CYP2D6 and CYP3A4
@ast
A pregnancy physiologically ba ...... d by CYP1A2, CYP2D6 and CYP3A4
@en
prefLabel
A pregnancy physiologically ba ...... d by CYP1A2, CYP2D6 and CYP3A4
@ast
A pregnancy physiologically ba ...... d by CYP1A2, CYP2D6 and CYP3A4
@en
P2093
P2860
P1476
A pregnancy physiologically ba ...... d by CYP1A2, CYP2D6 and CYP3A4
@en
P2093
Amin Rostami-Hodjegan
Khaled Abduljalil
Masoud Jamei
Trevor N Johnson
P2860
P304
P356
10.1111/J.1365-2125.2012.04363.X
P407
P577
2012-11-01T00:00:00Z